遇见数据集

Supplementary Table S6 from Checkpoint Blockade Combinations in Tumor Mutational Burden/Load-High Tumors: Insights from the Atezolizumab + Bevacizumab and Nivolumab + Ipilimumab Cohorts in the Drug Rediscovery Protocol

收藏
Figshare2025-12-01 更新2026-04-28 收录
二维码
社区交流群
二维码
科研交流群
商业服务